One68 Global Capital’s Pfizer PFE Stock Holding History

One68 Global Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$920K	Buy	25,000 +9,190	+58%	+$337K	1.85%	13
2020 Q3	$551K	Buy	+15,810	New	+$554K	1.46%	17

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

One68 Global Capital's PFE Position: Q4 2020 in Review

One68 Global Capital increased its Pfizer (PFE) stake by 58% in Q4 2020, buying an estimated $337K and bringing the position to 25,000 shares worth $920K. The position accounts for 1.85% of the portfolio, ranked #13.

One68 Global Capital first reported a position in PFE in Q3 2020 and has held it in 2 quarters since. 2,675 funds tracked by Wall St. Rank hold PFE as of Q4 2020.

One68 Global Capital held 25,000 shares of Pfizer worth $920K as of Q4 2020.
One68 Global Capital bought 9,190 Pfizer shares in Q4 2020, an estimated $337K.
Pfizer made up 1.85% of One68 Global Capital's portfolio in Q4 2020, its #13 holding.
One68 Global Capital first reported a position in Pfizer in Q3 2020 and has held it in 2 quarters since.
2,675 funds tracked by Wall St. Rank held Pfizer as of Q4 2020.

Based on One68 Global Capital's 13F filing for Q4 2020, filed 16 Feb 2021.